Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment
<h3>Purpose</h3><p dir="ltr">Cardiovascular disease (CVD) risk assessment is an important strategy for the prevention of CVD. Pharmacists play an important role in CVD risk assessment and management (CVDRAM). Our previous study identified gaps in knowledge among community...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , |
| Published: |
2020
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1864513524025262080 |
|---|---|
| author | Monica Zolezzi (10115698) |
| author2 | Oraib Abdallah (12506762) Sowndramalingam Sankaralingam (10221284) |
| author2_role | author author |
| author_facet | Monica Zolezzi (10115698) Oraib Abdallah (12506762) Sowndramalingam Sankaralingam (10221284) |
| author_role | author |
| dc.creator.none.fl_str_mv | Monica Zolezzi (10115698) Oraib Abdallah (12506762) Sowndramalingam Sankaralingam (10221284) |
| dc.date.none.fl_str_mv | 2020-06-22T03:00:00Z |
| dc.identifier.none.fl_str_mv | 10.2147/rmhp.s231075 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Development_and_Evaluation_of_an_Educational_Program_for_Community_Pharmacists_on_Cardiovascular_Risk_Assessment/25347796 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Health sciences Public health Human society Policy and administration community pharmacists cardiovascular disease risk assessment educational program pharmacists’ preparedness evaluation |
| dc.title.none.fl_str_mv | Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <h3>Purpose</h3><p dir="ltr">Cardiovascular disease (CVD) risk assessment is an important strategy for the prevention of CVD. Pharmacists play an important role in CVD risk assessment and management (CVDRAM). Our previous study identified gaps in knowledge among community pharmacists for the provision of CVDRAM services as assessed through patient simulation. Therefore, our objectives were: a) to develop and evaluate an educational program on CVD risk assessment for community pharmacists, b) to assess the knowledge and skills of participating pharmacists in assessing and managing CVD risk before and after enrolling in the educational program and c) to explore pharmacists’ satisfaction and perceived effectiveness of the educational program.</p><h3>Methods</h3><p dir="ltr">Using a blended learning instructional approach, the educational program for a subset of 25 community pharmacists recruited from our previous study consisted of two face-to-face workshops, and an online 5-module course on CVD risk factors such as hyperlipidemia, hypertension, diabetes, obesity, and smoking cessation based on principles of adult learning. A repeated measures study design was utilized by measuring participants’ knowledge on pre- and post-questionnaires and an objective structured clinical examination (OSCE) at the conclusion of the educational program was also used to assess its impact on the knowledge and skills of community pharmacists in the provision of CVD risk assessment and management (CVDRAM) services. The knowledge questionnaire was completed by 23 pharmacists while the OSCE was completed by 8 pharmacists. In addition, a survey assessed the pharmacists’ level of satisfaction with the educational program.</p><h3>Results</h3><p dir="ltr">At the conclusion of the educational program, the participating pharmacists achieved knowledge and skills for the provision of CVDRAM services. Knowledge scores in relation to CVDRAM significantly improved after the educational program [out of a maximum of 20 points, the median (interquartile range) = 9 (7– 9) at pre- vs 12 (12– 13) at post-educational program], p< 0.001. On the OSCE, the median (interquartile range) scores for Stations 1 and 2 were 66 (63– 71) and 71 (67– 76), respectively. Out of the 21 pharmacists that completed the satisfaction survey, 71% were very satisfied and 29% were satisfied with the educational program.</p><h3>Conclusion</h3><p dir="ltr">The educational program improved pharmacists’ knowledge and skills for the provision of CVDRAM services.</p><h2>Other Information</h2><p dir="ltr">Published in: Risk Management and Healthcare Policy<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.2147/rmhp.s231075" target="_blank">https://dx.doi.org/10.2147/rmhp.s231075</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_d6121f693b4f5638f67a2018324a6446 |
| identifier_str_mv | 10.2147/rmhp.s231075 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/25347796 |
| publishDate | 2020 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk AssessmentMonica Zolezzi (10115698)Oraib Abdallah (12506762)Sowndramalingam Sankaralingam (10221284)Health sciencesPublic healthHuman societyPolicy and administrationcommunity pharmacistscardiovascular disease risk assessmenteducational programpharmacists’ preparednessevaluation<h3>Purpose</h3><p dir="ltr">Cardiovascular disease (CVD) risk assessment is an important strategy for the prevention of CVD. Pharmacists play an important role in CVD risk assessment and management (CVDRAM). Our previous study identified gaps in knowledge among community pharmacists for the provision of CVDRAM services as assessed through patient simulation. Therefore, our objectives were: a) to develop and evaluate an educational program on CVD risk assessment for community pharmacists, b) to assess the knowledge and skills of participating pharmacists in assessing and managing CVD risk before and after enrolling in the educational program and c) to explore pharmacists’ satisfaction and perceived effectiveness of the educational program.</p><h3>Methods</h3><p dir="ltr">Using a blended learning instructional approach, the educational program for a subset of 25 community pharmacists recruited from our previous study consisted of two face-to-face workshops, and an online 5-module course on CVD risk factors such as hyperlipidemia, hypertension, diabetes, obesity, and smoking cessation based on principles of adult learning. A repeated measures study design was utilized by measuring participants’ knowledge on pre- and post-questionnaires and an objective structured clinical examination (OSCE) at the conclusion of the educational program was also used to assess its impact on the knowledge and skills of community pharmacists in the provision of CVD risk assessment and management (CVDRAM) services. The knowledge questionnaire was completed by 23 pharmacists while the OSCE was completed by 8 pharmacists. In addition, a survey assessed the pharmacists’ level of satisfaction with the educational program.</p><h3>Results</h3><p dir="ltr">At the conclusion of the educational program, the participating pharmacists achieved knowledge and skills for the provision of CVDRAM services. Knowledge scores in relation to CVDRAM significantly improved after the educational program [out of a maximum of 20 points, the median (interquartile range) = 9 (7– 9) at pre- vs 12 (12– 13) at post-educational program], p< 0.001. On the OSCE, the median (interquartile range) scores for Stations 1 and 2 were 66 (63– 71) and 71 (67– 76), respectively. Out of the 21 pharmacists that completed the satisfaction survey, 71% were very satisfied and 29% were satisfied with the educational program.</p><h3>Conclusion</h3><p dir="ltr">The educational program improved pharmacists’ knowledge and skills for the provision of CVDRAM services.</p><h2>Other Information</h2><p dir="ltr">Published in: Risk Management and Healthcare Policy<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.2147/rmhp.s231075" target="_blank">https://dx.doi.org/10.2147/rmhp.s231075</a></p>2020-06-22T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.2147/rmhp.s231075https://figshare.com/articles/journal_contribution/Development_and_Evaluation_of_an_Educational_Program_for_Community_Pharmacists_on_Cardiovascular_Risk_Assessment/25347796CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/253477962020-06-22T03:00:00Z |
| spellingShingle | Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment Monica Zolezzi (10115698) Health sciences Public health Human society Policy and administration community pharmacists cardiovascular disease risk assessment educational program pharmacists’ preparedness evaluation |
| status_str | publishedVersion |
| title | Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment |
| title_full | Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment |
| title_fullStr | Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment |
| title_full_unstemmed | Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment |
| title_short | Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment |
| title_sort | Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment |
| topic | Health sciences Public health Human society Policy and administration community pharmacists cardiovascular disease risk assessment educational program pharmacists’ preparedness evaluation |